- KR₩64bn
- KR₩65bn
- KR₩69bn
- 87
- 63
- 11
- 56
Annual balance sheet for Genesem, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,269 | 5,225 | 10,480 | 11,253 | 20,039 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 10,312 | 12,128 | 12,097 | 12,566 | 9,018 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 24,033 | 29,305 | 38,008 | 36,124 | 43,484 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 27,669 | 36,107 | 37,431 | 36,624 | 39,329 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 54,334 | 67,876 | 79,175 | 77,782 | 86,382 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18,748 | 18,714 | 27,469 | 27,280 | 29,712 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 38,220 | 40,312 | 38,943 | 35,192 | 36,393 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 16,114 | 27,564 | 40,233 | 42,591 | 49,989 |
Total Liabilities & Shareholders' Equity | 54,334 | 67,876 | 79,175 | 77,782 | 86,382 |
Total Common Shares Outstanding |